Reaction Details Report a problem with these data
Target
Platelet-activating factor receptor
Ligand
BDBM50011626
Substrate
n/a
Meas. Tech.
ChEBML_56498
IC50
7±n/a nM
Citation
 Walser, A; Flynn, T; Mason, C; Crowley, H; Maresca, C; Yaremko, B; O'Donnell, M Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor. J Med Chem 34:1209-21 (1991) [PubMed]  Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50011626
Synonyms:
4-{3-[6-(2-Fluoro-phenyl)-1-methyl-4H-2,3,5,10b-tetraaza-benzo[e]azulen-8-yl]-prop-2-ynyl}-4H-benzo[1,4]thiazin-3-one | CHEMBL277618
Type:
Small organic molecule
Emp. Form.:
C28H20FN5OS
Mol. Mass.:
493.555
SMILES:
Cc1nnc2CN=C(c3ccccc3F)c3cc(ccc3-n12)C#CCN1C(=O)CSc2ccccc12 |t:6|
Structure:
Search PDB for entries with ligand similarity: